Sort
85,873 grants matching “alzheimers”
EPIDEMIOLOGY OF DEMENTIA IN AN URBAN COMMUNITY
$2,405,115Columbia University Health Sciences · P01 · FY2003 · AG
Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham Cohorts
$2,404,965Sudha Seshadri · University Of Texas Hlth Science Center · R01 · FY2019 · AG
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology
$2,404,788Andrew J Saykin · Indiana University Indianapolis · U01 · FY2021 · AG
Identification and characterization of the CD31-ApoE-mCRP pathway for Alzheimer's disease in humans.
$2,404,559Wei Qiao Qiu · Boston University Medical Campus · RF1 · FY2023 · AG
Proteopathies of the Aging Central Nervous System
$2,402,472Lennart Mucke · J. David Gladstone Institutes · P01 · FY2007 · AG
Einstein Aging Study
$2,401,585Richard B. Lipton · Albert Einstein College Of Medicine · P01 · FY2019 · AG
High-resolution neural circuit dissection with controllers locally affecting synaptic partners (CLASP)
$2,400,000Evan Harriman Feinberg · University Of California, San Francisco · DP2 · FY2018 · MH
SBIR TOPIC 010 - TECHNOLOGY TO FACILITATE CHARACTERIZATION OF THE EXPOSOME IN UNDER-RESOURCED POPULATIONS FOR AD/ADRD STUDIES
$2,399,600Sanitta Thongpang · Seabright Llc · N43 · FY2025 · AG
Alzheimer's disease-specific extracellular vesicles: from pathology to novel biomarker discovery
$2,399,582Vasiliki Machairaki · Johns Hopkins University · RF1 · FY2023 · AG
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
$2,398,861Thomas M Wisniewski · New York University School Of Medicine · P01 · FY2022 · AG
Brain capillary endothelial cell energetics and neurovascular uncoupling in dementia
$2,398,590Fabrice Dabertrand · University Of Colorado Denver · RF1 · FY2024 · NS
Imaging Biomarker Core
$2,397,872Brian J Lopresti · University Of Pittsburgh At Pittsburgh · P01 · FY2022 · AG
MOLECULAR PATHOGENESIS OF AGE-DEPENDENT CNS DEGENERATION
$2,397,703University Of California San Francisco · P01 · FY2004 · AG
GLO1/Aβ-mediated mitochondrial and synaptic injury in Alzheimer's disease
$2,397,468Shi Du Yan · Columbia University Health Sciences · RF1 · FY2023 · AG
Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects
$2,396,962John Didsbury · T3d Therapeutics, Inc. · R01 · FY2020 · AG
Radon exposure in relation to the risk of cognitive impairment and mitochondrial function
$2,396,221Ka He · Columbia University Health Sciences · RF1 · FY2023 · AG
Neurobiology of Mild Cognitive Impairment in the Elderly
$2,396,025Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2023 · AG
Neurobiology of Mild Cognitive Impairment in the Elderly
$2,396,025Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2024 · AG
Frontotemporal Dementia: Genes, Images, and Emotions
$2,395,580Bruce L Miller · University Of California, San Francisco · P01 · FY2017 · AG
Causes and Consequences of Healthcare Efficiency
$2,395,557Amber E Barnato · Dartmouth College · P01 · FY2021 · AG
Dominantly Inherited Alzheimer Network Administrative Core
$2,394,859Randall J Bateman · Washington University · U19 · FY2020 · AG
Neurobiology of Mild Cognitive Impairment in the Elderly
$2,394,525Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2022 · AG
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
$2,394,473Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · RF1 · FY2023 · AG
Frontotemporal Dementias: Genotypes and Phenotypes
$2,394,324Virginia M Lee · University Of Pennsylvania · P01 · FY2016 · AG
PrEDICT ADRD: Predicting the Effects of Diagnosis in Individuals across Countries and Time in ADRD
$2,393,910Irene N Papanicolas · Brown University · RF1 · FY2024 · AG